Kent A. Griffith
Biochemistry, Genetics and Molecular Biology · University of Michigan
Publications
463
Citations
18,301
Est. group size
~25
Recurring co-author estimate
Active years
54
Publishing since 1973
Typically publishes in teams of ~8 · 5% small-team papers (≤3 authors) · across 22 venues
- Multi-institutional retrospective study of IDH2-mutated cholangiocarcinoma.
Journal of Clinical Oncology · 2026
- Acute Toxicity and Cosmesis Following a Tumor Bed Boost After Whole Breast Moderate Dose Hypofractionation
International Journal of Radiation Oncology*Biology*Physics · 2026
- Ovarian function suppression decision-making and uptake in premenopausal women with breast cancer: a mixed methods analysis
Breast Cancer Research and Treatment · 2026
- The Use of Breast Cup Immobilization in Radiation Therapy and Patient-Reported Outcomes on Cosmesis and Pain
Advances in Radiation Oncology · 2025
- An Innovative Program to Support Gender Equity and Success in Academic Medicine: Early Experiences From the Doris Duke Charitable Foundation's Fund to Retain Clinical Scientists.
UNC Libraries · 2025
- Reply to G.B. Mann et al and S. Sorscher
Journal of Clinical Oncology · 2024
- Abstract GS02-08: Five-year outcomes of the IDEA trial of endocrine therapy without radiotherapy after breast-conserving surgery for postmenopausal patients age 50-69 with genomically-selected favorable Stage I breast cancer
Cancer Research · 2024
- Association of Bilateral Salpingo-Oophorectomy With Cardiovascular Disease: Population Based Cohort Study
Journal of Minimally Invasive Gynecology · 2024
- Omission of Radiotherapy After Breast-Conserving Surgery for Women With Breast Cancer With Low Clinical and Genomic Risk: 5-Year Outcomes of IDEA
Journal of Clinical Oncology · 2023
- Carfilzomib, lenalidomide, and dexamethasone or lenalidomide alone as maintenance therapy after autologous stem-cell transplantation in patients with multiple myeloma (ATLAS): interim analysis of a randomised, open-label, phase 3 trial
The Lancet Oncology · 2023
- Longitudinal Assessment of Minimal Residual Disease (MRD) in the ATLAS Randomized Phase 3 Trial of Post-Transplant Treatment with Carfilzomib, Lenalidomide, and Dexamethasone (KRd) Versus Lenalidomide (R) Alone in Patients with Newly Diagnosed Multiple Myeloma (NDMM)
Blood · 2023
- Gender Composition in Biomedical Research Grant Submissions and Grant Review Panels Before Versus During the COVID-19 Pandemic
Journal of Women s Health · 2023
- Supplementary Table 2 from Preclinical and Clinical Studies of Gamma Secretase Inhibitors with Docetaxel on Human Breast Tumors
2023
- Supplementary Table 1 from Preclinical and Clinical Studies of Gamma Secretase Inhibitors with Docetaxel on Human Breast Tumors
2023
- Supplementary Table 1 from Preclinical and Clinical Studies of Gamma Secretase Inhibitors with Docetaxel on Human Breast Tumors
2023
- International Journal of Radiation Oncology*Biology*Physics×41
- Journal of Clinical Oncology×31
- JAMA Internal Medicine×6
- JAMA×5
- Journal of Women s Health×5
- Reshma Jagsi
Biochemistry, Genetics and Molecular Biology · University of Michigan
- Nicole M. Mott
Biochemistry, Genetics and Molecular Biology · University of Michigan
- Jamie Mills
Biochemistry, Genetics and Molecular Biology · University of Michigan
- Erin E. Burke
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Sara P. Myers
Biochemistry, Genetics and Molecular Biology · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile